Research Topics
| Julia M L BrothertonSummaryCountry: Australia Publications
| Collaborators
|
Detail Information
Publications
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination programSuzanne M Garland
Regional World Health Organisation Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
BMC Med 9:104. 2011..Prior to introduction of a national human papilloma virus (HPV) vaccination program, we determined HPV genotype prevalence by Indigenous status and residence in remote areas...
Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, AustraliaJulia M L Brotherton
Victorian Cytology Service, East Melbourne 8002, Victoria, Australia
Cancer Epidemiol 36:298-302. 2012..To assess human papillomavirus (HPV) vaccination coverage and attitudes to vaccination and Pap screening in young women...
Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillanceJulia M L Brotherton
Regional WHO Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
Future Microbiol 7:193-9. 2012....
Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methodsBette Liu
The Kirby Institute, University of New South Wales, Sydney, Australia
BMC Med Res Methodol 11:159. 2011..We therefore sought to examine the feasibility of recruiting young women for a national health survey through random digit dialling mobile phones...
National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination ProgramJulia M L Brotherton
Victorian Cytology Service, East Melbourne, Australia
Sex Health 7:291-8. 2010..We investigated GPs' experiences of delivering the HPV vaccine to women aged 18-26...
Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategyJulia M L Brotherton
Victorian Cytology Service, East Melbourne, Australia
Sex Health 7:310-9. 2010..Australia is well placed to monitor the impact of its HPV vaccination program as well as to measure vaccine effectiveness with existing HPV vaccines, cervical screening and cancer registries...
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological studyJulia M L Brotherton
Victorian Cytology Service Registries, Victorian Cytology Service, East Melbourne, Vic, Australia
Lancet 377:2085-92. 2011..We analysed trends in cervical abnormalities in women in Victoria, Australia, before and after introduction of the vaccination programme...
The incidence of genital warts in Australian women prior to the national vaccination programJulia M L Brotherton
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, Westmead, NSW 2145, Australia
Sex Health 6:178-84. 2009..A surveillance system capable of documenting any decrease in the incidence of genital warts and recurrent respiratory papillomatosis after vaccination is urgently required...
Interim estimates of human papillomavirus vaccination coverage in the school-based program in AustraliaJulia M L Brotherton
National Centre for Immunisation Research and Surveillance and University of Sydney, New South Wales
Commun Dis Intell Q Rep 32:457-61. 2008..Public sector immunisation providers across Australia should be commended for planning and implementing a new national immunisation program in approximately 4 months...
Primary prophylactic human papillomavirus vaccination programs: future perspective on global impactJulia M L Brotherton
National HPV Vaccination Program Register, Victorian Cytology Service Registries, Victorian Cytology Service, PO Box 310, East Melbourne, Victoria 8002, Australia
Expert Rev Anti Infect Ther 9:627-39. 2011..This article considers the current issues and challenges in delivering primary HPV vaccination programs effectively and the likely impact of the vaccines in both the near and more distant future...
Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program RegisterJulia Brotherton
National HPV Vaccination Program Register, East Melbourne, Victoria
Commun Dis Intell Q Rep 35:197-201. 2011..Some of the differences in the coverage observed between states and territories likely reflect differing mechanisms for notifying to the Register...
Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and preventionSuzanne M Garland
Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Melbourne, Victoria, Australia
Vaccine 26:M80-8. 2008..This represents a successful model for other countries. We present data on cervical cancer, risk factors and prevention strategies, including epidemiology of HPV and HPV vaccine strategies...
Fall in human papillomavirus prevalence following a national vaccination programSepehr N Tabrizi
Regional World Health Organization Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Victoria, Australia
J Infect Dis 206:1645-51. 2012..We evaluated the program's impact on genotype-specific HPV infection prevalence through a repeat survey of women attending clinical services...
"I just signed": Factors influencing decision-making for school-based HPV vaccination of adolescent girlsSpring Chenoa Cooper Robbins
Discipline of Paediatrics and Child Health, University of Sydney, Australia, at The Children s Hospital at Westmead, Sydney, Australia
Health Psychol 29:618-25. 2010..To date, there are no published studies describing decision-making processes and behavior postimplementation of HPV vaccination of adolescents participating in a school-based program...
Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, AustraliaDorota M Gertig
Victorian Cytology Service, PO Box 161, Carlton South, VIC 3053, Australia
Sex Health 8:171-8. 2011..Future monitoring of vaccine effectiveness will be facilitated by cross-linking to Pap test registries...
Adolescent and young adult HPV vaccination in Australia: achievements and challengesSuzanne M Garland
Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Parkville, Victoria, Australia
Prev Med 53:S29-35. 2011..Challenges for the future include how we can sustain and improve HPV vaccination coverage in young Australian women, while maintaining cervical cancer screening participation and reviewing cervical cancer screening methods...
How much cervical cancer in Australia is vaccine preventable? A meta-analysisJulia M L Brotherton
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, Locked Bag 4001, NSW 2145, Australia
Vaccine 26:250-6. 2008..7% of cervical cancers. This finding implies that Australia may have more to gain from the adoption of currently formulated HPV vaccines than other countries...
The predicted impact of vaccination on human papillomavirus infections in AustraliaMegan A Smith
Cancer Epidemiology Research Unit, The Cancer Council New South Wales, Woolloomooloo, New South Wales, Australia
Int J Cancer 123:1854-63. 2008..In conclusion, the current vaccination program is expected to result in a substantial and rapid reduction in the incidence of HPV16 in Australia...
Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in AustraliaAnthony T Newall
School of Public Health, University of Sydney, New South Wales, Australia
Clin Infect Dis 46:1647-55. 2008..Seroepidemiology is a valuable tool, although the relationship between HPV infection and seropositivity is incomplete...
Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in AustraliaJulia M L Brotherton
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia
Pediatrics 115:e643-6. 2005..This study aimed to determine the probability that an Australian infant who has died of SIDS was vaccinated in the days before death...
